Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03242850 · ClinicalTrials.gov registry record · NA

Assuring Patient-centered Literacy Promotion for Underserved Children Study

A NA study of Literacy, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT03242850 is a NA study of Literacy that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 160 participants, above the 112-participant average among 12 other Literacy trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03242850, a NA study of Literacy, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This study tests whether an enhanced primary cared based literacy promotion intervention consisting of a video and text message will increase shared reading occurrences between parents and children compared to the standard version.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention Group

Study Locations (1)

New Jersey

  • Eric B. Chandler Health Center - New Brunswick

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-01-24
Est. Completion 2019-08-24
Phase NA

What the Registry Record Tells You About NCT03242850

The ClinicalTrials.gov registry entry for NCT03242850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 12 other Literacy trials with a reported enrollment target (43% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Literacy appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group is the first listed.

NCT03242850 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03242850 about?

NCT03242850 is a clinical study titled "Assuring Patient-centered Literacy Promotion for Underserved Children Study". This study tests whether an enhanced primary cared based literacy promotion intervention consisting of a video and text message will increase shared reading occurrences between parents and children compared to the standard version.

What is the current status of trial NCT03242850?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-01-24. Estimated completion is 2019-08-24.

What conditions does trial NCT03242850 study?

This clinical trial studies the following conditions: Literacy.

What interventions are being tested in trial NCT03242850?

The interventions under investigation include: Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03242850?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03242850 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Literacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.